BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29732207)

  • 1. Oncological and functional efficacy of nephron-sparing surgery versus radical nephrectomy in renal cell carcinoma stages ≥cT1b: a single institution, matched analysis.
    Veys R; Abdollah F; Briganti A; Albersen M; Poppel HV; Joniau S
    Cent European J Urol; 2018; 71(1):48-57. PubMed ID: 29732207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncologic and Functional Outcomes after Partial Nephrectomy Versus Radical Nephrectomy in T1b Renal Cell Carcinoma: A Multicenter, Matched Case-Control Study in Korean Patients.
    Jang HA; Kim JW; Byun SS; Hong SH; Kim YJ; Park YH; Yang KS; Cho S; Cheon J; Kang SH
    Cancer Res Treat; 2016 Apr; 48(2):612-20. PubMed ID: 26044158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
    Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
    World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.
    Mir MC; Derweesh I; Porpiglia F; Zargar H; Mottrie A; Autorino R
    Eur Urol; 2017 Apr; 71(4):606-617. PubMed ID: 27614693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
    BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Outcome of Nephron-Sparing Surgery Compared to Radical Nephrectomy for Renal Cell Carcinoma ≥4 cm - A Matched-Pair Single Institution Analysis.
    Kalogirou C; Fender H; Muck P; Hey V; Krebs M; Riedmiller H; Vergho D
    Urol Int; 2017; 98(2):138-147. PubMed ID: 27505105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.
    Caputo PA; Zargar H; Ramirez D; Andrade HS; Akca O; Gao T; Kaouk JH
    Eur Urol; 2017 Jan; 71(1):111-117. PubMed ID: 27568064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is imperative partial nephrectomy feasible for kidney cancer with venous thrombus involvement? Outcomes of 42 cases and matched pair analysis with a large radical nephrectomy cohort.
    Marra G; Gontero P; Brattoli M; Filippini C; Capitanio U; Montorsi F; Daneshmand S; Huang WC; Linares Espinós E; Martínez-Salamanca JI; McKiernan JM; Zigeuner R; Libertino JA
    Urol Oncol; 2018 Jul; 36(7):339.e1-339.e8. PubMed ID: 29801993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overall survival and oncological outcomes after partial nephrectomy and radical nephrectomy for cT2a renal tumors: A collaborative international study from the French kidney cancer research network UroCCR.
    Reix B; Bernhard JC; Patard JJ; Bigot P; Villers A; Suer E; Vuong NS; Verhoest G; Alimi Q; Beauval JB; Benoit T; Nouhaud FX; Lenormand C; Hamidi N; Cai J; Eto M; Larre S; El Bakhri A; Ploussard G; Hung A; Koutlidis N; Schneider A; Carrouget J; Droupy S; Marchal S; Doerfler A; Seddik S; Matsugasumi T; Orsoni X; Descazeaud A; Pfister C; Bensalah K; Soulie M; Gill I; Flamand V;
    Prog Urol; 2018 Mar; 28(3):146-155. PubMed ID: 29331568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial versus radical nephrectomy in very elderly patients: a propensity score analysis of surgical, functional and oncologic outcomes (RESURGE project).
    Mir MC; Pavan N; Capitanio U; Antonelli A; Derweesh I; Rodriguez-Faba O; Linares E; Takagi T; Rha KH; Fiori C; Maurer T; Zang C; Mottrie A; Umari P; Long JA; Fiard G; De Nunzio C; Tubaro A; Tracey AT; Ferro M; De Cobelli O; Micali S; Bevilacqua L; Torres J; Schips L; Castellucci R; Dobbs R; Quarto G; Bove P; Celia A; De Concilio B; Trombetta C; Silvestri T; Larcher A; Montorsi F; Palumbo C; Furlan M; Bindayi A; Hamilton Z; Breda A; Palou J; Aguilera A; Tanabe K; Raheem A; Amiel T; Yang B; Lima E; Crivellaro S; Perdona S; Gregorio C; Barbati G; Porpiglia F; Autorino R
    World J Urol; 2020 Jan; 38(1):151-158. PubMed ID: 30937569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous Ablation Versus Partial and Radical Nephrectomy for T1a Renal Cancer: A Population-Based Analysis.
    Talenfeld AD; Gennarelli RL; Elkin EB; Atoria CL; Durack JC; Huang WC; Kwan SW
    Ann Intern Med; 2018 Jul; 169(2):69-77. PubMed ID: 29946703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial vs Radical Nephrectomy for T1-T2 Renal Masses in the Elderly: Comparison of Complications, Renal Function, and Oncologic Outcomes.
    An JY; Ball MW; Gorin MA; Hong JJ; Johnson MH; Pavlovich CP; Allaf ME; Pierorazio PM
    Urology; 2017 Feb; 100():151-157. PubMed ID: 27889493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial versus radical nephrectomy for T1b-2N0M0 renal tumors: A propensity score matching study based on the SEER database.
    Zhang M; Zhao Z; Duan X; Deng T; Cai C; Wu W; Zeng G
    PLoS One; 2018; 13(2):e0193530. PubMed ID: 29489911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of survival rates in stage 1 renal cell carcinoma between partial nephrectomy and radical nephrectomy patients according to age distribution: a propensity score matching study.
    Takagi T; Kondo T; Iizuka J; Omae K; Kobayashi H; Yoshida K; Hashimoto Y; Tanabe K
    BJU Int; 2016 Jun; 117(6B):E52-9. PubMed ID: 26073989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncologic Outcomes of Partial Nephrectomy for Stage T3a Renal Cell Cancer.
    Shvero A; Nativ O; Abu-Ghanem Y; Zilberman D; Zaher B; Levitt M; Fridman E; Portnoy O; Ramon J; Dotan ZA
    Clin Genitourin Cancer; 2018 Jun; 16(3):e613-e617. PubMed ID: 29174471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of overall survival and perioperative outcomes between partial and radical nephrectomy for cT1b and cT2 renal cell carcinoma-Analysis of a national cancer registry.
    Venkatramani V; Koru-Sengul T; Miao F; Nahar B; Prakash NS; Swain S; Punnen S; Ritch C; Gonzalgo M; Parekh D
    Urol Oncol; 2018 Mar; 36(3):90.e9-90.e14. PubMed ID: 29254672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robotic partial nephrectomy vs minimally invasive radical nephrectomy for clinical T2a renal mass: a propensity score-matched comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group.
    Bradshaw AW; Autorino R; Simone G; Yang B; Uzzo RG; Porpiglia F; Capitanio U; Porter J; Bertolo R; Minervini A; Lau C; Jacobsohn K; Ashrafi A; Eun D; Mottrie A; White WM; Schips L; Challacombe BJ; De Cobelli O; Mir CM; Veccia A; Larcher A; Kutikov A; Aron M; Dasgupta P; Montorsi F; Gill IS; Sundaram CP; Kaouk J; Derweesh IH
    BJU Int; 2020 Jul; 126(1):114-123. PubMed ID: 32232920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Partial and Radical Nephrectomy for pT1b Renal Cell Carcinoma.
    Kim JM; Song PH; Kim HT; Park TC
    Korean J Urol; 2010 Sep; 51(9):596-600. PubMed ID: 20856643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing Outcomes for Patients with Clinical T1b Renal Cell Carcinoma Treated With Either Percutaneous Microwave Ablation or Surgery.
    Shapiro DD; Wells SA; Best SL; Hedican SP; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Lee FT; Jarrard DF; Richards KA; Downs TM; Allen GO; Nakada SY; Abel EJ
    Urology; 2020 Jan; 135():88-94. PubMed ID: 31585198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base.
    Ristau BT; Handorf EA; Cahn DB; Kutikov A; Uzzo RG; Smaldone MC
    Cancer; 2018 Oct; 124(19):3839-3848. PubMed ID: 30207380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.